Dr. Tamara Maes
Founder and Chief Scientific Officer of the company from its foundation in 2000 until 2 November 2020, and member of Oryzon’s Board of Directors since its foundation and First Vice Chair. She received her PhD. in Biotechnology (genetics) from the University of Ghent (Belgium). She is also a director of MENDELION LIFESCIENCES, S.L., she was a member of the Scientific Advisory Board of the Consejo Superior de Investigaciones Científicas (CSIC) from January 2009 to January 2013, is a member of the Scientific Review Board of the Alzheimer’s Drug Discovery Foundation since 2016 and has collaborated with CAIXA CAPITAL RISC in its mentoring program for new entrepeneurs since September 1, 2015. She joins Oryzon’s Scientific Advisory Board as President of this board in November 2020.